Centre for Integrated Genomic Medical Research (CIGMR), School of Medicine, University of Manchester, 2.722 Stopford Building, Oxford Road, Manchester, M13 9PT, UK.
Immunogenetics. 2013 Apr;65(4):291-7. doi: 10.1007/s00251-013-0680-2. Epub 2013 Jan 29.
Canine hypoadrenocorticism is an endocrine disorder characterised by inadequate secretion of steroid hormones from the adrenal glands. Pathology results from immune-mediated destruction of the adrenal cortex, which is similar to that seen in the human Addison's disease. Both the canine and human diseases have similar clinical presentation, with the diagnosis based on performing a dynamic adrenocorticotropic hormone stimulation test. MHC class II has previously been associated with the human and canine diseases. In the current study, we conducted an MHC class II association study in eight breeds of dog with diagnoses of hypoadrenocorticism. We demonstrated significant differences in dog leukocyte antigen (DLA) haplotype frequencies in six of these breeds: Cocker spaniel, Springer spaniel, Labrador, West Highland white terrier (WHWT), Bearded collie, and Standard poodle. In the Springer spaniel, the DLA-DRB1015:01--DQA1006:01--DQB1023:01 haplotype was significantly associated with disease risk (p = 0.014, odds ratio (OR) = 5.14) and showed a similar trend in the Cocker spaniel. This haplotype is related to one associated with hypoadrenocorticism in the Nova Scotia duck tolling retriever. Similar haplotypes shared between breeds were demonstrated, with DLA-DRB1001:01--DQA1001:01--DQB1002:01 more prevalent in both affected Labrador (p = 0.0002, OR = 3.06) and WHWT (p = 0.01, OR = 2.11). Other haplotypes that have not previously been associated with the disease were identified. The inter-breed differences in DLA haplotypes associated with susceptibility to canine hypoadrenocorticism could represent divergent aetiologies. This could have implications for clinical diagnosis and future comparative studies. Alternatively, it may suggest that the gene of interest is closely linked to the MHC.
犬肾上腺皮质功能减退症是一种内分泌疾病,其特征是肾上腺分泌的类固醇激素不足。其病理学结果是由肾上腺皮质的免疫介导破坏引起的,类似于人类的艾迪生病。犬和人类的疾病都有相似的临床表现,其诊断基于进行促肾上腺皮质激素刺激试验。MHC Ⅱ类基因此前与人类和犬类疾病有关。在目前的研究中,我们对被诊断为肾上腺皮质功能减退症的 8 个犬种进行了 MHC Ⅱ类关联研究。我们在其中 6 个犬种中发现了犬白细胞抗原(DLA)单倍型频率的显著差异:可卡猎鹬犬、史宾格犬、拉布拉多犬、西部高地白梗犬、粗毛牧羊犬和标准贵宾犬。在史宾格犬中,DLA-DRB1015:01--DQA1006:01--DQB1023:01 单倍型与疾病风险显著相关(p=0.014,优势比(OR)=5.14),在可卡猎鹬犬中也表现出相似的趋势。该单倍型与与新斯科舍诱鸭寻回猎犬相关的单倍型有关。在不同品种之间展示了相似的共享单倍型,在受影响的拉布拉多犬(p=0.0002,OR=3.06)和西部高地白梗犬(p=0.01,OR=2.11)中,DLA-DRB1001:01--DQA1001:01--DQB1002:01 更为普遍。还确定了以前与该疾病无关的其他单倍型。与犬肾上腺皮质功能减退症易感性相关的 DLA 单倍型的种间差异可能代表了不同的病因。这可能对临床诊断和未来的比较研究有影响。或者,这可能表明感兴趣的基因与 MHC 紧密相关。